$10.88
0.333.13%
At close: Dec 15, 4:00 PM EST
$10.76
-0.12-1.10%
After Hours: 7:55 PM EST
Comments
Loading...
Amicus Therapeutics Stock Guidance | NASDAQ:FOLD | Benzinga
Amicus Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/04/2025 | FOLD | Amicus Therapeutics | FY | 2025 | — | — | — | $607.54M | $644.52M | $626.04M | Get Alert |
| 07/31/2025 | FOLD | Amicus Therapeutics | FY | 2025 | — | — | — | $607.54M | $644.52M | $621.32M | Get Alert |
| 05/01/2025 | FOLD | Amicus Therapeutics | FY | 2025 | — | — | — | $607.54M | $644.52M | $631.23M | Get Alert |
| 02/19/2025 | FOLD | Amicus Therapeutics | FY | 2025 | — | — | — | $618.11M | $655.09M | $636.01M | Get Alert |
| 01/12/2025 | FOLD | Amicus Therapeutics | Q4 | 2024 | — | — | — | $149.90M | $149.90M | $147.53M | Get Alert |
| 01/12/2025 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $528.50M | $528.50M | $526.12M | Get Alert |
| 11/06/2024 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $519.16M | $527.15M | $517.07M | Get Alert |
| 08/08/2024 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $503.19M | $523.16M | $510.32M | Get Alert |
| 05/09/2024 | FOLD | Amicus Therapeutics | FY | 2024 | — | — | — | $499.19M | $519.16M | $529.99M | Get Alert |
| 01/07/2024 | FOLD | Amicus Therapeutics | FY | 2023 | — | — | — | $399.40M | $399.40M | $396.45M | Get Alert |
| 01/09/2023 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $329.00M | $329.00M | $326.68M | Get Alert |
| 08/04/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $355.01M | Get Alert |
| 05/09/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $363.85M | Get Alert |
| 02/24/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $375.35M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | Q4 | 2021 | — | — | — | $84.00M | $84.00M | $84.77M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | FY | 2022 | — | — | — | $350.00M | $365.00M | $396.55M | Get Alert |
| 01/10/2022 | FOLD | Amicus Therapeutics | FY | 2021 | — | — | — | $306.00M | $306.00M | $308.46M | Get Alert |
FAQ
Q
What is the most recent guidance for Amicus Therapeutics (FOLD)?
A
There have been no specific sales or earnings guidance reported for Amicus Therapeutics in recent months.
Browse guidance and forecast on all stocks.
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved